VA's Pharmacy Prime Vendor Contract for June 2017 Reached $265.6M with McKesson Corporation
Contract Overview
Contract Amount: $265,637,385 ($265.6M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2017-06-01
End Date: 2017-06-30
Contract Duration: 29 days
Daily Burn Rate: $9.2M/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 5
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY17 JUN 1, 2017 TO JUN 30, 2017 CONTRACT VA797P-12-D-0001
Place of Performance
Location: SAN FRANCISCO, SAN FRANCISCO County, CALIFORNIA, 94104
Plain-Language Summary
Department of Veterans Affairs obligated $265.6 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY17 JUN 1, 2017 TO JUN 30, 2017 CONTRACT VA797P-12-D-0001 Key points: 1. The contract, valued at $265.6 million for June 2017, highlights significant spending in pharmaceutical procurement. 2. McKesson Corporation is a major player in the pharmaceutical distribution market, indicating a competitive landscape. 3. The primary risk lies in potential price fluctuations and supply chain disruptions for essential medications. 4. This spending falls within the Healthcare sector, specifically pharmaceutical preparation manufacturing.
Value Assessment
Rating: good
The contract's pricing is based on a Firm Fixed Price (FFP) structure, which provides cost certainty. Benchmarking against similar large-scale pharmaceutical contracts is difficult without specific product-level data, but the overall value suggests a significant volume of goods and services.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a robust price discovery process. This method aims to secure the best value for the government by allowing all eligible sources to compete.
Taxpayer Impact: The competitive nature of this award is intended to ensure taxpayer funds are used efficiently for essential pharmaceutical supplies.
Public Impact
Ensures a steady supply of pharmaceuticals for veterans, impacting healthcare access and quality. Supports a critical component of the VA's healthcare delivery system. Reflects the government's significant investment in healthcare services for its veteran population.
Waste & Efficiency Indicators
Waste Risk Score: 75 / 10
Warning Flags
- Potential for price increases in future contract periods.
- Dependence on a single vendor for a large volume of pharmaceuticals.
Positive Signals
- Awarded through full and open competition.
- Firm Fixed Price contract provides cost predictability.
Sector Analysis
The healthcare sector, particularly pharmaceutical preparation manufacturing, is a substantial area of government spending. Benchmarks for such large-scale contracts are often tied to market dynamics and the specific therapeutic areas covered.
Small Business Impact
This contract appears to be awarded to a large corporation (McKesson Corporation), with no explicit indication of small business participation in this specific delivery order. Further analysis would be needed to determine if subcontracting opportunities exist for small businesses.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract. Robust oversight is crucial to ensure timely delivery, quality of pharmaceuticals, and adherence to contract terms, safeguarding taxpayer investment.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Vendor concentration risk
- Potential for price volatility
- Supply chain disruption risk
- Dependence on a single contract for a critical service
Tags
pharmaceutical-preparation-manufacturing, department-of-veterans-affairs, ca, delivery-order, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $265.6 million to MCKESSON CORPORATION. EXPRESS REPORT: PHARMACY PRIME VENDOR CMOP FY17 JUN 1, 2017 TO JUN 30, 2017 CONTRACT VA797P-12-D-0001
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $265.6 million.
What is the period of performance?
Start: 2017-06-01. End: 2017-06-30.
What is the historical price trend for this contract over multiple years?
Analyzing historical pricing data for this Pharmacy Prime Vendor contract would reveal trends in cost escalation or reduction. Understanding these trends is crucial for forecasting future expenditures and identifying potential cost-saving opportunities or areas of concern regarding price inflation.
What is the risk associated with relying on a single vendor for such a critical supply chain?
Reliance on a single vendor, even one as established as McKesson, presents risks such as supply chain disruptions due to unforeseen events (natural disasters, geopolitical issues, or internal company problems). This could lead to medication shortages, impacting veteran care and potentially requiring emergency procurement at higher costs.
How effectively does the current pricing structure ensure value for money compared to alternative procurement methods?
The Firm Fixed Price (FFP) structure provides cost certainty, which is a form of value. However, assessing true value for money requires comparing the negotiated prices against market benchmarks and considering the total cost of ownership, including administrative overhead and potential for price adjustments.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 5
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: ONE POST ST, SAN FRANCISCO, CA, 94104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $265,637,385
Exercised Options: $265,637,385
Current Obligation: $265,637,385
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: VA797P12D0001
IDV Type: IDC
Timeline
Start Date: 2017-06-01
Current End Date: 2017-06-30
Potential End Date: 2017-06-30 00:00:00
Last Modified: 2019-08-20
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)